Belinostat (PXD101) to Treat Tumors of the Thymus at an Advanced Stage

NCT00589290 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

NIH

Sponsor class

Conditions

Thymoma
Thymic Carcinoma

Interventions

DRUG: Belinostat (PDX101)

Sponsor

National Cancer Institute (NCI)